Phio Pharmaceuticals Corp. (PHIO)
NASDAQ · Healthcare
Phio Pharmaceuticals Corp. Operating Income 2012–2020
Phio Pharmaceuticals Corp. annual/quarterly operating income history and growth rate from 2012 to 2020. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Phio Pharmaceuticals Corp. operating income for the quarter ending September 30, 2020 was -2.3 M, a 9.13% increase year-over-year.
- Phio Pharmaceuticals Corp. operating income for the twelve months ending September 30, 2020 was -8.4 M, a 11.16% increase year-over-year.
- Phio Pharmaceuticals Corp. annual operating income for 2020 was -8.8 M, a 2.16% decrease from 2019.
- Phio Pharmaceuticals Corp. annual operating income for 2019 was -9.0 M, a 22.04% increase from 2018.
- Phio Pharmaceuticals Corp. annual operating income for 2018 was -7.4 M, a 47.63% decrease from 2017.
- Phio Pharmaceuticals Corp. annual operating income for 2017 was -14.1 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Phio Pharmaceuticals Corp. Operating Income — FAQ
Phio Pharmaceuticals Corp. (PHIO) operating income over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Phio Pharmaceuticals Corp.'s operating income?
Phio Pharmaceuticals Corp. (PHIO) reported operating income of -$9M for fiscal 2020.
Where can I see PHIO's operating income history?
The chart and table above show Phio Pharmaceuticals Corp.'s operating income by year and by quarter, including the growth rate.